➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Harvard Business School
Moodys
Johnson and Johnson
Dow

Last Updated: June 12, 2021

DrugPatentWatch Database Preview

Litigation Details for iCeutica Pty Ltd. v. Novitium Pharma LLC (D. Del. 2018)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in iCeutica Pty Ltd. v. Novitium Pharma LLC
The small molecule drug covered by the patents cited in this case is   Get Started Free .

Details for iCeutica Pty Ltd. v. Novitium Pharma LLC (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-04-20 1 United States Patent Nos. 9,526,734 (“the ’734 patent”), 9,649,318 (“the ’318 patent”), and 9,808,468…734, ’318, and ’468 patents no later than when each patent was issued by the Patent Office and/or listed… expiration date of the ’734 patent, the ’318 patent, or the ’468 patent, as extended by any applicable…to the expiration of the ’734 patent, the ’318 patent, or the ’468 patent, as extended …to the expiration of the ’734 patent, the ’318 patent, or the ’468 patent, as extended by any applicable External link to document
2020-01-21 108 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,526,734; 9,649,318; 9,808,468…2018 22 January 2020 1:18-cv-00599 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff External link to document
2018-04-20 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,526,734; 9,649,318; 9,808,468…2018 22 January 2020 1:18-cv-00599 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff External link to document
2019-09-23 97 Order - -Memorandum and Order States Patent Nos. 9,526,734 (the "#734 patent"), 9,649,318 (the "#318 patent"),…9,808,468 (the "#468 patent"). D.I. 1 at ,r 1. The asserted patents cover Plaintiffs' VIVLODEX…10mg, before the expiration of the" asserted patents. D.I. 76 at 1. The deadline for leave to…counterclaims, seeking to assert that the asserted patents are invalid as indefinite under 35 U.S.C. § 112…2018 22 January 2020 1:18-cv-00599 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
McKinsey
Harvard Business School
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.